Mineralys Therapeutics (MLYS) Share-based Compensation (IS) (2022 - 2026)
Mineralys Therapeutics' Share-based Compensation (IS) came in at $7.36 million for Q2 2026, up 61.5% from $4.55 million a year earlier and up 12.3% from the prior quarter.
Powered by 
Analysis
Mineralys Therapeutics (MLYS) Share-based Compensation (IS) (2022 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Mineralys Therapeutics reported Share-based Compensation (IS) of $25.03 million, up 73.0% year-over-year; for FY2025, it came in at $19.32 million, up 70.5% from FY2024.
- Share-based Compensation (IS) carries a three-year compound annual growth rate of 248.9% (FY2022 to FY2025).
- Going back by year, Share-based Compensation (IS) was $11.34 million in FY2024 (+124.0%), $5.06 million in FY2023 and $455,000 in FY2022.
- The Q2 2026 figure represents the highest quarterly Share-based Compensation (IS) in data going back to Q1 2022.
- Year-over-year, Share-based Compensation (IS) has increased for 12 consecutive quarters, with growth averaging 79.4% over the last eight quarters.
- Across the past five years, year-over-year growth in Share-based Compensation (IS) ran from 58.5% in Q2 2025 to 721.9% in Q3 2023.
- Business Quant data shows MLYS's Share-based Compensation (IS) at $6.55 million (Q1 2026), $5.29 million (Q4 2025) and $5.84 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | - |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | - |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | - |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | - |
| 10 | Mineralys Therapeutics | 2.26 Bn | 2.26 Bn | - | 7.36 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.36 Mn |
| Mar 31, 2026 | 6.55 Mn |
| Dec 31, 2025 | 5.29 Mn |
| Sep 30, 2025 | 5.84 Mn |
| Jun 30, 2025 | 4.55 Mn |
| Mar 31, 2025 | 3.65 Mn |
| Dec 31, 2024 | 3.13 Mn |
| Sep 30, 2024 | 3.14 Mn |
| Jun 30, 2024 | 2.87 Mn |
| Mar 31, 2024 | 2.19 Mn |
| Dec 31, 2023 | 1.46 Mn |
| Sep 30, 2023 | 1.58 Mn |
| Jun 30, 2023 | 1.28 Mn |
| Mar 31, 2023 | 749,000.00 |
| Dec 31, 2022 | 218,000.00 |
| Sep 30, 2022 | 192,000.00 |
| Jun 30, 2022 | 26,000.00 |
| Mar 31, 2022 | 19,000.00 |
API Access
Mineralys Therapeutics Share-based Compensation (IS) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=MLYS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation-is", "ticker": "MLYS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=MLYS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();